These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38745531)

  • 1. Development of new hormonal male contraception for the couple.
    Kroopnick JM; Lee MS; Blithe DL
    Andrology; 2024 Oct; 12(7):1506-1511. PubMed ID: 38745531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
    Amory JK; Blithe DL; Sitruk-Ware R; Swerdloff RS; Bremner WJ; Dart C; Liu PY; Thirumalai A; Nguyen BT; Anawalt BD; Lee MS; Page ST; Wang C
    Contraception; 2023 Aug; 124():110064. PubMed ID: 37210024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.
    Roth MY; Shih G; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Sitruk-Ware R; Blithe DL; Amory JK
    Contraception; 2014 Oct; 90(4):407-12. PubMed ID: 24981149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.
    Anawalt BD; Roth MY; Ceponis J; Surampudi V; Amory JK; Swerdloff RS; Liu PY; Dart C; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Page ST; Wang C
    Andrology; 2019 Nov; 7(6):878-887. PubMed ID: 30969032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
    Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal male contraception: progress and prospects for the 21st century.
    Handelsman DJ
    Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male contraception: narrative review of ongoing research.
    Louwagie EJ; Quinn GFL; Pond KL; Hansen KA
    Basic Clin Androl; 2023 Nov; 33(1):30. PubMed ID: 37940863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.
    Ly LP; Liu PY; Handelsman DJ
    Hum Reprod; 2005 Jun; 20(6):1733-40. PubMed ID: 15860500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive efficacy of a depot progestin and androgen combination in men.
    Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging approaches to male contraception.
    Thirumalai A; Amory JK
    Fertil Steril; 2021 Jun; 115(6):1369-1376. PubMed ID: 33931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.
    Long JE; Lee MS; Blithe DL
    J Clin Endocrinol Metab; 2021 May; 106(6):e2381-e2392. PubMed ID: 33481994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male hormonal contraception. What prospects exist and how acceptable are they?
    Griffin D; Ringheim K
    Plan Parent Chall; 1996; (2):20-4. PubMed ID: 12291936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal male contraception.
    Wang C; Meriggiola MC; Behre HM; Page ST
    Andrology; 2024 Oct; 12(7):1551-1557. PubMed ID: 39016284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal Male Contraception: Getting to Market.
    Page ST; Blithe D; Wang C
    Front Endocrinol (Lausanne); 2022; 13():891589. PubMed ID: 35721718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male contraception development: monitoring effective spermatogenesis suppression utilizing a user-controlled sperm concentration test compared with standard semen analysis.
    Lue Y; Swerdloff R; Pak Y; Nguyen BT; Yuen F; Liu PY; Blithe DL; Wang C
    Fertil Steril; 2023 Feb; 119(2):208-217. PubMed ID: 36347310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male contraception.
    Wu FC
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):1-23. PubMed ID: 8736719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.
    Roth MY; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Dart C; Sitruk-Ware R; Kumar N; Blithe D; Amory JK
    Andrology; 2013 Nov; 1(6):899-905. PubMed ID: 24123845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
    Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.